Pfizer faced challenges with data scattered across multiple systems, causing cumbersome manual processes and hindering collaboration in drug discovery. By implementing a three-stage AVEVA PI System, Pfizer digitized its drug discovery process, achieving 50% faster compliance reporting, 90% quicker alarm resolution, and a 50% reduction in BMS reporting. This enhanced data visibility and operations monitoring critical to Pfizer’s complex research, development, and manufacturing, enabling more efficient processes and supporting the company’s mission to improve patient outcomes globally.

Join for free to read